[English] 日本語
Yorodumi- PDB-3et1: Structure of PPARalpha with 3-[5-Methoxy-1-(4-methoxy-benzenesulf... -
+
Open data
-
Basic information
| Entry | Database: PDB / ID: 3et1 | ||||||
|---|---|---|---|---|---|---|---|
| Title | Structure of PPARalpha with 3-[5-Methoxy-1-(4-methoxy-benzenesulfonyl)-1H-indol-3-yl]-propionic acid | ||||||
 Components | 
  | ||||||
 Keywords | Transcription/Transferase / PPAR / PPARa / PPARalpha / Drug Discovery / Diabetes / adiponectin / metabolic disease / fragment-based drug discovery / scaffold-based drug discovery / Activator / DNA-binding / Metal-binding / Nucleus / Polymorphism / Receptor / Transcription / Transcription regulation / Zinc / Zinc-finger / Acyltransferase / Alternative splicing / Chromosomal rearrangement / Phosphoprotein / Proto-oncogene / Transferase / Ubl conjugation / Transcription-Transferase COMPLEX | ||||||
| Function / homology |  Function and homology informationpositive regulation of transformation of host cell by virus / regulation of fatty acid transport / enamel mineralization / positive regulation of fatty acid beta-oxidation / regulation of ketone metabolic process / cellular response to fructose stimulus / regulation of fatty acid metabolic process / negative regulation of cell growth involved in cardiac muscle cell development / negative regulation of appetite / negative regulation of hepatocyte apoptotic process ...positive regulation of transformation of host cell by virus / regulation of fatty acid transport / enamel mineralization / positive regulation of fatty acid beta-oxidation / regulation of ketone metabolic process / cellular response to fructose stimulus / regulation of fatty acid metabolic process / negative regulation of cell growth involved in cardiac muscle cell development / negative regulation of appetite / negative regulation of hepatocyte apoptotic process / lipoprotein metabolic process / positive regulation of fatty acid oxidation / behavioral response to nicotine / negative regulation of leukocyte cell-cell adhesion / labyrinthine layer morphogenesis / positive regulation of transcription from RNA polymerase II promoter by galactose / regulation of thyroid hormone receptor signaling pathway / positive regulation of female receptivity / negative regulation of glycolytic process / ubiquitin conjugating enzyme binding / mitogen-activated protein kinase kinase kinase binding / NR1H2 & NR1H3 regulate gene expression to control bile acid homeostasis / positive regulation of fatty acid metabolic process / DNA-binding transcription activator activity / male mating behavior / NFAT protein binding / hypothalamus development / negative regulation of cholesterol storage / positive regulation of ATP biosynthetic process / nuclear steroid receptor activity / cellular response to Thyroglobulin triiodothyronine / Synthesis of bile acids and bile salts / negative regulation of macrophage derived foam cell differentiation / progesterone receptor signaling pathway / Synthesis of bile acids and bile salts via 27-hydroxycholesterol / epidermis development / Endogenous sterols / Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol / response to retinoic acid / phosphatase binding / estrous cycle / nuclear retinoid X receptor binding / positive regulation of lipid biosynthetic process / histone acetyltransferase activity / cellular response to hormone stimulus / Recycling of bile acids and salts / Transcriptional regulation of brown and beige adipocyte differentiation by EBF2 / histone acetyltransferase / NR1H3 & NR1H2 regulate gene expression linked to cholesterol transport and efflux / negative regulation of blood pressure / intracellular receptor signaling pathway / nitric oxide metabolic process / estrogen receptor signaling pathway / negative regulation of reactive oxygen species biosynthetic process / hormone-mediated signaling pathway / lactation / :  / positive regulation of adipose tissue development / Regulation of lipid metabolism by PPARalpha / MDM2/MDM4 family protein binding / peroxisome proliferator activated receptor signaling pathway / response to nutrient / positive regulation of neuron differentiation / positive regulation of gluconeogenesis / negative regulation of cytokine production involved in inflammatory response / regulation of cellular response to insulin stimulus / negative regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction / BMAL1:CLOCK,NPAS2 activates circadian expression / SUMOylation of transcription cofactors / Activation of gene expression by SREBF (SREBP) / response to progesterone / negative regulation of miRNA transcription / cerebellum development / cellular response to starvation / nuclear estrogen receptor binding / nuclear receptor binding / gluconeogenesis / RNA polymerase II transcription regulatory region sequence-specific DNA binding / hippocampus development / SUMOylation of intracellular receptors / circadian regulation of gene expression / mRNA transcription by RNA polymerase II / wound healing / Heme signaling / fatty acid metabolic process / negative regulation of transforming growth factor beta receptor signaling pathway / Transcriptional activation of mitochondrial biogenesis / PPARA activates gene expression / Cytoprotection by HMOX1 / response to insulin / regulation of circadian rhythm / cerebral cortex development / Nuclear Receptor transcription pathway / Transcriptional regulation of white adipocyte differentiation / negative regulation of inflammatory response / DNA-binding transcription repressor activity, RNA polymerase II-specific / RNA polymerase II transcription regulator complex / transcription coactivator binding / male gonad development / nuclear receptor activity Similarity search - Function  | ||||||
| Biological species |  Homo sapiens (human) | ||||||
| Method |  X-RAY DIFFRACTION /  SYNCHROTRON /  MOLECULAR REPLACEMENT / Resolution: 2.5 Å  | ||||||
 Authors | Zhang, K.Y.J. / Wang, W. | ||||||
 Citation |  Journal: Proc.Natl.Acad.Sci.USA / Year: 2009Title: Scaffold-based discovery of indeglitazar, a PPAR pan-active anti-diabetic agent Authors: Artis, D.R. / Lin, J.J. / Zhang, C. / Wang, W. / Mehra, U. / Perreault, M. / Erbe, D. / Krupka, H.I. / England, B.P. / Arnold, J. / Plotnikov, A.N. / Marimuthu, A. / Nguyen, H. / Will, S. / ...Authors: Artis, D.R. / Lin, J.J. / Zhang, C. / Wang, W. / Mehra, U. / Perreault, M. / Erbe, D. / Krupka, H.I. / England, B.P. / Arnold, J. / Plotnikov, A.N. / Marimuthu, A. / Nguyen, H. / Will, S. / Signaevsky, M. / Kral, J. / Cantwell, J. / Settachatgull, C. / Yan, D.S. / Fong, D. / Oh, A. / Shi, S. / Womack, P. / Powell, B. / Habets, G. / West, B.L. / Zhang, K.Y. / Milburn, M.V. / Vlasuk, G.P. / Hirth, K.P. / Nolop, K. / Bollag, G. / Ibrahim, P.N. / Tobin, J.F.  | ||||||
| History | 
  | 
-
Structure visualization
| Structure viewer | Molecule:  Molmil Jmol/JSmol | 
|---|
-
Downloads & links
-
Download
| PDBx/mmCIF format |  3et1.cif.gz | 128.4 KB | Display |  PDBx/mmCIF format | 
|---|---|---|---|---|
| PDB format |  pdb3et1.ent.gz | 99.9 KB | Display |  PDB format | 
| PDBx/mmJSON format |  3et1.json.gz | Tree view |  PDBx/mmJSON format | |
| Others |  Other downloads | 
-Validation report
| Summary document |  3et1_validation.pdf.gz | 1.1 MB | Display |  wwPDB validaton report | 
|---|---|---|---|---|
| Full document |  3et1_full_validation.pdf.gz | 1.1 MB | Display | |
| Data in XML |  3et1_validation.xml.gz | 24.7 KB | Display | |
| Data in CIF |  3et1_validation.cif.gz | 32.9 KB | Display | |
| Arichive directory |  https://data.pdbj.org/pub/pdb/validation_reports/et/3et1 ftp://data.pdbj.org/pub/pdb/validation_reports/et/3et1 | HTTPS FTP  | 
-Related structure data
| Related structure data | ![]() 3et0C ![]() 3et2C ![]() 3et3C ![]() 1kkqS C: citing same article ( S: Starting model for refinement  | 
|---|---|
| Similar structure data | 
-
Links
-
Assembly
| Deposited unit | ![]() 
  | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| 1 | ![]() 
  | ||||||||
| 2 | ![]() 
  | ||||||||
| Unit cell | 
  | 
-
Components
| #1: Protein | Mass: 32874.246 Da / Num. of mol.: 2 / Fragment: LIGAND BINDING DOMAIN Source method: isolated from a genetically manipulated source Source: (gene. exp.)  Homo sapiens (human) / Gene: PPARA, NR1C1, PPAR / Plasmid: pET-28 / Production host: ![]() #2: Protein/peptide | Mass: 1965.281 Da / Num. of mol.: 2 / Fragment: residues 681-696 Source method: isolated from a genetically manipulated source Source: (gene. exp.)  Homo sapiens (human) / Gene: NCOA1, SRC1 / Plasmid: pET-28 / Production host: ![]() #3: Chemical | #4: Water |  ChemComp-HOH /  |  | 
|---|
-Experimental details
-Experiment
| Experiment | Method:  X-RAY DIFFRACTION / Number of used crystals: 1  | 
|---|
-
Sample preparation
| Crystal | Density Matthews: 2.73 Å3/Da / Density % sol: 54.88 % | 
|---|---|
| Crystal grow | Temperature: 277 K / pH: 8  Details: The purified PPARa LBD protein was diluted to 10 mg/ml and 1mM of indeglitazar and 2x molar excess of SRC-1 peptide were added prior to crystallization by mixing equal volumes of ...Details: The purified PPARa LBD protein was diluted to 10 mg/ml and 1mM of indeglitazar and 2x molar excess of SRC-1 peptide were added prior to crystallization by mixing equal volumes of protein/compound sample with reservoir solution containing 16% PEG 8000, 0.1 M Tris buffer at pH 8.0, 0.02 M lithium sulfate, and 5% glycerol, VAPOR DIFFUSION, SITTING DROP, temperature 277K  | 
-Data collection
| Diffraction | Mean temperature: 93 K | 
|---|---|
| Diffraction source | Source:  SYNCHROTRON / Site:  ALS   / Beamline: 8.3.1 / Wavelength: 1.1  | 
| Detector | Type: ADSC QUANTUM 210 / Detector: CCD / Date: Jul 14, 2005 | 
| Radiation | Protocol: SINGLE WAVELENGTH / Monochromatic (M) / Laue (L): M / Scattering type: x-ray | 
| Radiation wavelength | Wavelength: 1.1 Å / Relative weight: 1 | 
| Reflection | Resolution: 2.5→50 Å / Num. obs: 26993 / % possible obs: 99.8 % / Observed criterion σ(I): 0 / Redundancy: 4.8 % / Rsym value: 0.045 | 
| Reflection shell | Resolution: 2.5→2.57 Å / Redundancy: 4.9 % / Mean I/σ(I) obs: 1.3 / Rsym value: 0.319 / % possible all: 99.5 | 
-
Processing
| Software | 
  | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Refinement | Method to determine structure:  MOLECULAR REPLACEMENTStarting model: PDB entry 1KKQ Resolution: 2.5→44.8 Å / SU ML: 0.41 / σ(F): 1.35 / Phase error: 26.67 / Stereochemistry target values: ML 
  | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Solvent computation | Shrinkage radii: 0.9 Å / VDW probe radii: 1.11 Å / Solvent model: FLAT BULK SOLVENT MODEL / Bsol: 68.83 Å2 / ksol: 0.34 e/Å3 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Displacement parameters | 
  | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Refinement step | Cycle: LAST / Resolution: 2.5→44.8 Å
  | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Refine LS restraints | 
  | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| LS refinement shell | 
  | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Refinement TLS params. | Method: refined / Refine-ID: X-RAY DIFFRACTION 
  | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Refinement TLS group | 
  | 
Movie
Controller
About Yorodumi



Homo sapiens (human)
X-RAY DIFFRACTION
Citation

















PDBj


















